Catheter-related blood stream infections (CRBSI): A European view

Nephrology Dialysis Transplantation

Volumn 25, Issue 6, 2010, Pages 1753-1756

  Vanholder, Raymond ^a   Canaud, Bernard ^b   Fluck, Richard ^c   Jadoul, Michel ^d   Labriola, Laura ^d   Marti Monros, Anna ^e   Tordoir, Jan ^f   Van Biesen, Wim ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b LAPEYRONIE HOSPITAL   (France)

^c ROYAL DERBY HOSPITAL   (United Kingdom)

^d CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^e HOSPITAL GENERAL UNIVERSITARIO DE VALENCIA   (Spain)

^f MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC THERAPY; BLOOD CULTURE; CATHETER INFECTION; CENTRAL VENOUS CATHETER; HEMODIALYSIS; INFECTION PREVENTION; NOTE; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; ANTIFUNGAL AGENTS; CATHETER-RELATED INFECTIONS; CATHETERIZATION, CENTRAL VENOUS; EUROPE; HUMANS; PRACTICE GUIDELINES AS TOPIC; RENAL DIALYSIS; SEPSIS;

EID: 77952988363     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfq205     Document Type: Note

References (40)

1. Mermel LA, Allon M, Bouza E et al. Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009; 49: 1-45
2. Vanholder R, Canaud B, Fluck R et al. Diagnosis, prevention and treatment of haemodialysis catheter-related blood stream infections (CRBSI): a position statement of European Renal Best Practice (ERBP). NDT Plus 2010; 3: 234-246
3. Zoccali C, Abramowicz D, Cannata-Andia JB et al. European best practice quo vadis? From European Best Practice Guidelines (EBPG) to European Renal Best Practice (ERBP). Nephrol Dial Transplant 2008; 23: 2162-2166
4. Vanholder R, Abramowicz D, Cannata-Andia JB et al. The future of European nephrology 'guidelines'\a declarationof intentbyEuropean Renal Best Practice (ERBP). NDT Plus 2009; 2: 213-221
5. Locatelli F, Covic A, Eckardt KU et al. Anaemia management in patients with chronic kidney disease: a position statement by the Anaemia Working Group of European Renal Best Practice (ERBP). Nephrol Dial Transplant 2009; 24: 348-354
6. Covic A, Abramowicz D, Bruchfeld A et al. Endorsement of the Kidney Disease Improving Global Outcomes (KDIGO) hepatitis C guidelines: a European Renal Best Practice (ERBP) position statement. Nephrol Dial Transplant 2009; 24: 719-727
7. Tattersall J, Canaud B, Heimburger O et al. High-flux or low-flux dialysis: a position statement following publication of the Membrane Permeability Outcome study. Nephrol Dial Transplant 2010; 25: 1230-1232
8. Tordoir J, Canaud B, Haage P et al. EBPG on vascular access. Nephrol Dial Transplant 2007; 22: ii88-117
9. Oliver MJ, Callery SM, Thorpe KE et al. Risk of bacteremia from temporary hemodialysis catheters by site of insertion and duration of use: a prospective study. Kidney Int 2000; 58: 2543-2545
10. Droste JC, Jeraj HA, MacDonald A et al. Stability and in vitro efficacy of antibiotic-heparin lock solutions potentially useful for treatment of central venous catheter-related sepsis. J Antimicrob Chemother 2003; 51: 849-855
11. Regamey C, Schaberg D, Kirby WM. Inhibitory effect of heparin on gentamicin concentrations in blood. Antimicrob Agents Chemother 1972; 1: 329-332
12. Shanks RM, Sargent JL, Martinez RM et al. Catheter lock solutions influence staphylococcal biofilm formation on abiotic surfaces. Nephrol Dial Transplant 2006; 21: 2247-2255
13. Yahav D, Rozen-Zvi B, Gafter-Gvili A et al. Antimicrobial lock solutions for the prevention of infections associated with intravascular catheters in patients undergoing hemodialysis: systematic review and meta-analysis of randomized, controlled trials. Clin Infect Dis 2008; 47: 83-93
14. Labriola L, Crott R, Jadoul M. Preventing haemodialysis catheter-related bacteraemia with an antimicrobial lock solution: a meta-analysis of prospective randomized trials. Nephrol Dial Transplant 2008; 23: 1666-1672
15. Winnett G, Nolan J, Miller M et al. Trisodium citrate 46.7% selectively and safely reduces staphylococcal catheter-related bacteraemia. Nephrol Dial Transplant 2008; 23: 3592-3598
16. Allon M. Prophylaxis against dialysis catheter-related bacteremia with a novel antimicrobial lock solution. Clin Infect Dis 2003; 36: 1539-1544
17. Weijmer MC, van den Dorpel MA, Van d V et al. Randomized, clinical trial comparison of trisodium citrate 30% and heparin as catheter-locking solution in hemodialysis patients. J Am Soc Nephrol 2005; 16: 2769-2777
18. Lok CE, Appleton D, Bhola C et al. Trisodium citrate 4%\an alternative to heparin capping of haemodialysis catheters. Nephrol Dial Transplant 2007; 22: 477-483
19. Betjes MG, van Agteren M. Prevention of dialysis catheter-related sepsis with a citrate-taurolidine-containing lock solution. Nephrol Dial Transplant 2004; 19: 1546-1551
20. Polaschegg HD, Sodemann K. Safety of concentrated trisodium citrate catheter locks. Nephrol Dial Transplant 2008; 23: 4075-4076
21. Soriano A, Bregada E, Marques JM et al. Decreasing gradient of antibiotic concentration in the lumen of catheters locked with van-comycin. Eur J Clin Microbiol Infect Dis 2007; 26: 659-661
22. Moran JE, Ash SR. Locking solutions for hemodialysis catheters; heparin and citrate\a position paper by ASDIN. Semin Dial 2008; 21: 490-492
23. Landry D, Sweet S, Gobeiile S et al. Long-term gentamycin lock catheter profylaxis is associated with gentamycin-resistant gram-positive bacteremias in chronic hemodialysis patients. http://www.ab-stracts2view.com/asn (abstract ASN 2009) (15 November 2009, date last accessed).
24. Beathard GA, Urbanes A. Infection associated with tunneled hemo-dialysis catheters. Semin Dial 2008; 21: 528-538
25. Rabindranath KS, Bansal T, Adams J et al. Systematic review of antimicrobials for the prevention of haemodialysis catheter-related infections. Nephrol Dial Transplant 2009; 24: 3763-3774
26. James MT, Conley J, Tonelli M et al. Meta-analysis: antibiotics for prophylaxis against hemodialysis catheter-related infections. Ann Intern Med 2008; 148: 596-605
27. Tacconelli E, Carmeli Y, Aizer A et al. Mupirocin prophylaxis to prevent Staphylococcus aureus infection in patients undergoing dialysis: a meta-analysis. Clin Infect Dis 2003; 37: 1629-1638
28. Perez-Fontan M, Rosales M, Rodriguez-Carmona A et al. Mupirocin resistance after long-term use for Staphylococcus aureus colonization in patients undergoing chronic peritoneal dialysis. Am J Kidney Dis 2002; 39: 337-341
29. Lok CE, Stanley KE, Hux JE et al. Hemodialysis infection prevention with polysporin ointment. J Am Soc Nephrol 2003; 14: 169-179
30. Maki DG, Weise CE, Sarafin HW. A semiquantitative culture method for identifying intravenous-catheter-related infection. N Engl J Med 1977; 296: 1305-1309
31. Park KH, Kim SH, Song EH et al. Development of bacteraemia or fungaemia after removal of colonized central venous catheters in patients with negative concomitant blood cultures. Clin Microbiol Infect 2009
32. Bouza E, Alvarado N, Alcala L et al. A randomized and prospective study of 3 procedures for the diagnosis of catheter-related bloodstream infection without catheter withdrawal. Clin Infect Dis 2007; 44: 820-826
33. Allon M. Treatment guidelines for dialysis catheter-related bacter-emia: an update. Am J Kidney Dis 2009; 54: 13-17
34. Fortun J, Grill F, Martin-Davila P et al. Treatment of long-term intra-vascular catheter-related bacteraemia with antibiotic-lock therapy. J Antimicrob Chemother 2006; 58: 816-821
35. Ashby DR, Power A, Singh S et al. Bacteremia associated with tunneled hemodialysis catheters: outcome after attempted salvage. Clin J Am Soc Nephrol 2009; 4: 1601-1605
36. Stryjewski ME, Szczech LA, Benjamin DK Jr et al. Use of vancomy-cin or first-generation cephalosporins for the treatment of hemodial-ysis-dependent patients with methicillin-susceptible Staphylococcus aureus bacteremia. Clin Infect Dis 2007; 44: 190-196
37. Kuhn DM, George T, Chandra J et al. Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins. Antimicrob Agents Chemother 2002; 46: 1773-1780
38. Ruhe J, Menon A, Mushatt D et al. Non-epidermidis coagulase-neg-ative staphylococcal bacteremia: clinical predictors of true bacter-emia. Eur J Clin Microbiol Infect Dis 2004; 23: 495-498
39. Kielstein JT, Lorenzen J, Kaever Vet al. Risk of underdosing of am-picillin/sulbactam in patients with acute kidney injury undergoing extended daily dialysis\single case. Nephrol Dial Transplant 2009; 24: 2283-2285
40. Maya ID, Carlton D, Estrada E et al. Treatment of dialysis catheter-related Staphylococcus aureus bacteremia with an antibiotic lock: a quality improvement report. Am J Kidney Dis 2007; 50: 289-295